Amneal Pharmaceuticals Inc. (AMRX) |
|
4.91 -0.07 (-1.41%)
|
02-14 16:00 |
|
Open: |
4.96 |
Pre. Close: |
4.98 |
|
High:
|
5.11 |
Low:
|
4.845 |
|
Volume:
|
710,359 |
Market Cap:
|
1529M |
|
|
|
|
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. It operates through two segments, Generics and Specialty. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, manufacture, and sale of branded pharmaceutical products primarily for central nervous system disorders and parasitic infections. It also offers licensed and owned, niche, and mature branded products, as well as Rytary for the treatment of Parkinsons Disease; Zomig for the treatment of migraine headaches; Emverm a chewable tablets for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
5.106 - 5.138 |
5.138 - 5.161 |
|
Low:
|
4.924 - 4.964 |
4.964 - 4.992 |
|
Close:
|
4.859 - 4.916 |
4.916 - 4.956 |
|
Technical analysis |
as of: 2020-02-14 4:26:32 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 5.99 One year: 6.63 |
| Support: |
Support1: 4.23 Support2: 3.52 |
| Resistance: |
Resistance1: 5.13 Resistance2: 5.68 |
| Pivot: |
4.79  |
| Moving Average: |
MA(5): 5.02 MA(20): 4.86
MA(100): 3.88 MA(250): 6.46 |
| MACD: |
MACD(12,26): 0.09 Signal(9): 0.09 |
| Stochastic oscillator: |
%K(14,3): 70.64 %D(3): 72.20 |
| RSI: |
RSI(14): 53.27 |
| 52-week: |
High: 14.79 Low: 2.27 Change(%): -65.0 |
| Average Vol(K): |
3-Month: 288266 10-Days: 95428 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.AMRX has closed below upper band by 35.3%. Bollinger Bands are 28.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2020-01-16
Should Value Investors Pick Amneal Pharma (AMRX) Stock Now?
Let's see if Amneal Pharmaceuticals (AMRX) stock is a good choice for value-oriented investors right now from multiple angles.
2019-12-12
Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today
As the saying goes, good things come to those who wait, and following a year of decline, patience might finally be paying off … The post Here’s Why Amneal Pharmaceuticals (AMRX) Stock Skyrocketed 50% Today appeared first on Smarter Analyst .
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Specialty Generic |
| Shares Out. (M) |
134.10 |
| Shares Float (M) |
82.30 |
|
% Held by Insiders
|
13.07 |
|
% Held by Institutions
|
76.30 |
|
Shares Short (K)
|
5760 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-2.635 |
|
Book Value (p.s.)
|
1.630 |
|
PEG Ratio
|
-3.70 |
|
Profit Margin
|
-19.61 |
|
Operating Margin
|
4.54 |
|
Return on Assets (ttm)
|
1.2 |
|
Return on Equity (ttm)
|
-85.3 |
|
Qtrly Rev. Growth
|
-20.6 |
|
Gross Profit (p.s.)
|
5.494 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
2.350 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
312.24 |
|
Levered Free Cash Flow (M)
|
310.76 |
Stock Valuations |
|
P/E
|
-1.86 |
|
P/E Growth Ratio
|
-0.01 |
|
P/BV
|
3.01 |
|
P/S
|
0.36 |
|
P/CF
|
2.11 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
